Literature DB >> 16969583

GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men.

Krishnaswamy Vijayalakshmi1, Kumarasamy Thangaraj2, Singh Rajender2, Venkatesan Vettriselvi1, Perumal Venkatesan3, Sunil Shroff4, K N Vishwanathan5, Solomon F D Paul6.   

Abstract

The ethnic variation in the GGN and CAG microsatellites of the androgen receptor (AR) gene suggests their role in the substantial racial difference in prostate cancer risk. Hence, we performed a case-control study to assess whether GGN repeats independently or in combination with CAG repeats were associated with prostate cancer risk in South Indian men. The repeat lengths of the AR gene determined by Gene scan analysis, revealed that men with GGN repeats <or=21 had no significant risk compared to those with >21 repeats (OR 0.91 at 95% CI-0.52-1.58). However, when CAG repeats of our earlier study was combined with the GGN repeat data, the cases exhibited significantly higher frequency of the haplotypes CAG <or=19/GGN <or=21 (OR-5.2 at 95% CI-2.17-12.48, P < 0.001) and CAG <or=19/GGN > 21(OR-6.9 at 95%CI-2.85-17.01, P < 0.001) compared to the controls. No significant association was observed between GGN repeats and prostate-specific antigen levels and the age at diagnosis. Although a trend of short GGN repeats length in high-grade was observed, it was not significant (P = 0.09). Overall, our data reveals that specific GGN/CAG haplotypes (CAG <or=19/GGN <or=21 and CAG <or=19/GGN > 21) of AR gene increase the risk of prostate cancer and thus could serve as susceptibility marker for prostate cancer in South Indian men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969583     DOI: 10.1007/s10038-006-0051-z

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  25 in total

1.  Association between hormonal genetic polymorphisms and early-onset prostate cancer.

Authors:  M S Forrest; S M Edwards; R Houlston; Z Kote-Jarai; T Key; N Allen; M A Knowles; F Turner; A Ardern-Jones; A Murkin; S Williams; R Oram; D T Bishop; R A Eeles
Journal:  Prostate Cancer Prostatic Dis       Date:  2005       Impact factor: 5.554

Review 2.  The endocrinology and developmental biology of the prostate.

Authors:  G R Cunha; A A Donjacour; P S Cooke; S Mee; R M Bigsby; S J Higgins; Y Sugimura
Journal:  Endocr Rev       Date:  1987-08       Impact factor: 19.871

3.  Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.

Authors:  S Lu; S Y Tsai; M J Tsai
Journal:  Cancer Res       Date:  1997-10-15       Impact factor: 12.701

4.  Re: Prostate cancer and the androgen receptor.

Authors:  G A Coetzee; R K Ross
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

5.  Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.

Authors:  J L Stanford; J J Just; M Gibbs; K G Wicklund; C L Neal; B A Blumenstein; E A Ostrander
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

6.  (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population.

Authors:  L Correa-Cerro; G Wöhr; J Häussler; P Berthon; E Drelon; P Mangin; G Fournier; O Cussenot; P Kraus; W Just; T Paiss; J M Cantú; W Vogel
Journal:  Eur J Hum Genet       Date:  1999-04       Impact factor: 4.246

Review 7.  Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.

Authors:  V Nwosu; J Carpten; J M Trent; R Sheridan
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

8.  Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

Authors:  A W Hsing; Y T Gao; G Wu; X Wang; J Deng; Y L Chen; I A Sesterhenn; F K Mostofi; J Benichou; C Chang
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

9.  Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.

Authors:  Bao-li Chang; Siqun L Zheng; Gregory A Hawkins; Sarah D Isaacs; Kathy E Wiley; Aubrey Turner; John D Carpten; Eugene R Bleecker; Patrick C Walsh; Jeffrey M Trent; Deborah A Meyers; William B Isaacs; Jianfeng Xu
Journal:  Hum Genet       Date:  2002-01-23       Impact factor: 4.132

10.  The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

Authors:  N L Chamberlain; E D Driver; R L Miesfeld
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

View more
  6 in total

1.  Decision tree-based modeling of androgen pathway genes and prostate cancer risk.

Authors:  Jill S Barnholtz-Sloan; Xiaowei Guan; Charnita Zeigler-Johnson; Neal J Meropol; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

2.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

Review 3.  Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes.

Authors:  Charnita M Zeigler-Johnson; Elaine Spangler; Mohamed Jalloh; Serigne M Gueye; Hanna Rennert; Timothy R Rebbeck
Journal:  Can J Urol       Date:  2008-02       Impact factor: 1.344

Review 4.  Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence.

Authors:  Kitty Kit Ting Cheung; Andrea On Yan Luk; Wing Yee So; Ronald Ching Wan Ma; Alice Pik Shan Kong; Francis Chun Chung Chow; Juliana Chung Ngor Chan
Journal:  J Diabetes Investig       Date:  2014-11-03       Impact factor: 4.232

Review 5.  Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.

Authors:  Rufus Cartwright; Altaf Mangera; Kari A O Tikkinen; Prabhakar Rajan; Jori Pesonen; Anna C Kirby; Ganesh Thiagamoorthy; Chris Ambrose; Juan Gonzalez-Maffe; Phillip R Bennett; Tom Palmer; Andrew Walley; Marjo-Riitta Järvelin; Vik Khullar; Chris Chapple
Journal:  Eur Urol       Date:  2014-01-22       Impact factor: 20.096

6.  Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.

Authors:  Hong Weng; Sheng Li; Jing-Yu Huang; Zi-Qi He; Xiang-Yu Meng; Yue Cao; Cheng Fang; Xian-Tao Zeng
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.